ICU-acquired central line-associated bloodstream infection and its associated factors in Oman

AL-Shukri, Rehab Nasser; AL-Rawajfah, Omar M.; Al-Daken, Laila; Al-Busaidi, Mujahid

doi:10.1016/j.ajic.2021.12.024

Cited by 5 publications

(2 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar to other types of healthcare-associated infections [ 17 ], the results from this study revealed that the incidence rate of SSIs after CABG surgeries in Oman is high compared to the reported rates from the developing countries. Comparison and discussion of this rate are presented in a previous publication [ 5 ].…”

Section: Discussionsupporting

confidence: 73%

Healthcare costs and outcomes associated with surgical site infections after coronary artery bypass grafting surgeries in Oman

et al. 2023

Self Cite

View full text Add to dashboard Cite

Background Surgical site infection (SSI) after coronary artery bypass graft (CABG) surgeries is considered a key indicator of the quality of healthcare services. Objective This study aimed to estimate the healthcare outcomes associated with SSIs after CABG surgeries in Oman in terms of mortality rate, case-fatality rate, LOS, readmission rate and healthcare costs. Methods The nested case-control study design was used based on retrospective data, which was conducted from 2016 to 2017. The case group encompassed all CABG patients with confirmed SSIs within 30 days of the surgery ( n = 104) while controls were CABG patients without SSIs ( n = 404). Results Forty-four (42.3%) of the SSI patients were readmitted to the hospital compared to eight (2%) of the control group ( p < .001). Patients in the case group had a longer LOS ( M = 24.4, SD = 44.6 days) compared to those in the control group ( M = 11, SD = 21 days, p = .003). The mean healthcare costs of cases ( M = Omani Rial [OMR] 3823, SD = OMR 2516) were significantly greater than controls ( M = OMR 3154, SD = OMR 1415, p = .010). Conclusion Results from this study can be baseline data for formulating new hypotheses and testing the causal relationship between SSIs after CABG surgeries and the readmission rate, LOS and health care costs. Key messages Surgical Site Infections (SSIs) are still a major complication after cardiac surgeries in Oman. SSIs after cardiac surgeries are associated with substantially increased healthcare costs and length of stay. SSIs after cardiac surgeries are associated with negative outcomes such as mortality and case-fatality rates.

show abstract

Section: Discussionsupporting

confidence: 73%

Healthcare costs and outcomes associated with surgical site infections after coronary artery bypass grafting surgeries in Oman

et al. 2023

Self Cite

View full text Add to dashboard Cite

show abstract

“…[2][3][4][5] The average incidence of CRBSI in ICUs in China is 1.5/1000 catheter days, 6 similar to the rates in UK, Germany and Italy, 7 but lower than the rates reported in Oman. 8 This may be partly due to the different definitions of surveillance, diagnosis criteria, patient conditions, and catheterization of procedures in different countries and regions. CLABSI incidence showed regional differences in China.…”

Section: Introductionmentioning

confidence: 99%

Incidence Rate, Pathogens and Economic Burden of Catheter-Related Bloodstream Infection: A Single-Center, Retrospective Case-Control Study

Zhang¹,

Wang²,

Sheng³

et al. 2023

IDR

View full text Add to dashboard Cite

Purpose Indwelling central venous catheters (CVCs) can cause catheter related bloodstream infection (CRBSI). CRBSI occurring in intensive care unit (ICU) patients may lead to the worse outcomes and extra medical costs. The present study aimed to assess the incidence and incidence density, pathogens and economic burden of CRBSI in ICU patients. Patients and Methods A case-control study was retrospectively carried out in six ICUs of one hospital between July 2013 and June 2018. The Department of Infection Control performed routinely surveillance for CRBSI on these different ICUs. Data of the clinical and microbiological characteristics of patients with CRBSI, the incidence and incidence density of CRBSI in ICUs, the attributable length of stay (LOS), and the costs among patients with CRBSI in ICU were collected and assessed. Results A total of 82 ICU patients with CRBSI were included into the study. The CRBSI incidence density was 1.27 per 1000 CVC-days in all ICUs, in which the highest was 3.52 per 1000 CVC-days in hematology ICU and the lowest was 0.14 per 1000 CVC-days in Special Procurement ICU. The most common pathogen causing CRBSI was Klebsiella pneumoniae (15/82, 16.67%), in which 12 (80%) were carbapenem resistant. Fifty-one patients were successfully matched with control patients. The average costs in the CRBSI group were $ 67,923, which were significantly higher (P < 0.001) than the average costs in the control group. The total average costs attributable to CRBSI were $33, 696. Conclusion The medical costs of ICU patients were closely related to the incidence of CRBSI. Imperative measures are needed to reduce CRBSI in ICU patients.

show abstract

Multinational prospective cohort study of incidence and risk factors for central line-associated bloodstream infections in ICUs of 8 Latin American countries

Rosenthal¹,

Jin²,

Valderrama-Beltrán³

et al. 2023

American Journal of Infection Control

View full text Add to dashboard Cite

ICU-acquired central line-associated bloodstream infection and its associated factors in Oman

Cited by 5 publications

References 35 publications

Healthcare costs and outcomes associated with surgical site infections after coronary artery bypass grafting surgeries in Oman

Healthcare costs and outcomes associated with surgical site infections after coronary artery bypass grafting surgeries in Oman

Incidence Rate, Pathogens and Economic Burden of Catheter-Related Bloodstream Infection: A Single-Center, Retrospective Case-Control Study

Multinational prospective cohort study of incidence and risk factors for central line-associated bloodstream infections in ICUs of 8 Latin American countries

Contact Info

Product

Resources

About